Effect of interferon-beta-1b on cognitive functions in multiple sclerosis.

Abstract

INTRODUCTION Multiple sclerosis (MS) is recognised as a central nervous system disease also affecting cognition. The rate of cognitive dysfunction in MS is in the range of 45-65% and adversely affect the quality of life. OBJECTIVE To evaluate the effect of 1 year of treatment with interferon-beta-1b (IFNbeta-1b) on cognitive functions in patients… (More)

Topics

  • Presentations referencing similar topics